Randomised Study to Compare the Efficacy of AZD6244 vs TMZ

Completed · Phase 2

Conditions studied: Melanoma

In brief

The primary purpose of this study is to compare the efficacy of AZD6244 (ARRY-142886) with temozolomide in patients with advanced melanoma

Key facts

Study ID
NCT00338130
Run by
AstraZeneca
People needed
239
Starts
2006-07-01
Expected to finish
2013-07-01
Last updated by the study team
2014-08-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.